Literature DB >> 17984569

Molecular basis of endocrine regulation by orphan nuclear receptor Small Heterodimer Partner.

Dipanjan Chanda1, Jeong-Hoh Park, Hueng-Sik Choi.   

Abstract

Nuclear receptors (NRs) are a unique superfamily of transcription factors (TFs) which are involved in and play a crucial role in almost all aspects of mammalian physiology. Small Heterodimer Partner (SHP; NR0B2), an exceptional member of this superfamily of NRs, have been identified as a key regulatory factor of the transcription of a variety of genes involved in diverse metabolic pathways, and are thereby an important factor in a variety of physiological functions. Since its discovery a decade ago, considerable progress has been made in the elucidation of the underlying mechanism by which SHP regulates various metabolic processes, and the results of previous studies support its importance in the maintenance of metabolic homeostasis. In this review, we have evaluated the current state of understanding of the molecular mechanisms and the resultant physiological interpretations governed by SHP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984569     DOI: 10.1507/endocrj.k07e-103

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  51 in total

1.  Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice.

Authors:  Yanjun Jiang; Jingling Jin; Polina Iakova; Julio Cesar Hernandez; Nicole Jawanmardi; Emily Sullivan; Grace L Guo; Nikolai A Timchenko; Gretchen J Darlington
Journal:  Mech Ageing Dev       Date:  2013-09-02       Impact factor: 5.432

Review 2.  The orphan nuclear receptors at their 25-year reunion.

Authors:  Shannon E Mullican; Joanna R Dispirito; Mitchell A Lazar
Journal:  J Mol Endocrinol       Date:  2013-11-26       Impact factor: 5.098

3.  Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice.

Authors:  Xian Pan; Rebecca Kent; Kyoung-Jae Won; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2017-02-02       Impact factor: 3.922

Review 4.  Transcriptional Regulation of CYP2D6 Expression.

Authors:  Xian Pan; Miaoran Ning; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2016-10-03       Impact factor: 3.922

5.  Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP.

Authors:  Xiaoyue Pan; Yuxia Zhang; Li Wang; M Mahmood Hussain
Journal:  Cell Metab       Date:  2010-08-04       Impact factor: 27.287

6.  The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors.

Authors:  Jae-Min Yuk; Dong-Min Shin; Hye-Mi Lee; Jwa-Jin Kim; Sun-Woong Kim; Hyo Sun Jin; Chul-Su Yang; Kyeong Ah Park; Dipanjan Chanda; Don-Kyu Kim; Song Mei Huang; Sang Ki Lee; Chul-Ho Lee; Jin-Man Kim; Chang-Hwa Song; Soo Young Lee; Gang Min Hur; David D Moore; Hueng-Sik Choi; Eun-Kyeong Jo
Journal:  Nat Immunol       Date:  2011-07-03       Impact factor: 25.606

7.  Farnesoid X receptor activation mediates head-to-tail chromatin looping in the Nr0b2 gene encoding small heterodimer partner.

Authors:  Guodong Li; Ann M Thomas; Steven N Hart; Xiaobo Zhong; Dequan Wu; Grace L Guo
Journal:  Mol Endocrinol       Date:  2010-05-05

8.  Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes.

Authors:  Ji Miao; Sung-E Choi; Sun Mi Seok; Linda Yang; William J Zuercher; Yong Xu; Timothy M Willson; H Eric Xu; Jongsook Kim Kemper
Journal:  Mol Endocrinol       Date:  2011-05-12

Review 9.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

10.  Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation.

Authors:  Dipanjan Chanda; Yuan-Bin Xie; Hueng-Sik Choi
Journal:  Nucleic Acids Res       Date:  2010-04-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.